OICHARTS
8 AMThe 8 AM report →

BMLLBio Medica Laboratories Limited share price

NSE · INE1BKA01015 · 83 sessions on record
₹167.80▲ +4.75 · +2.9%from ₹163.05 the session before · 15 Oct 2026 close · NSE end of day
Open
₹160.00
High
₹167.80
Low
₹160.00
Day's range
₹7.84.8% of the previous close
VWAP
₹160.85close +4.3% from it
Volume, shares
13,0000.83× the 20-session average
Turnover, ₹ crore
0.21
Trades
7.01,900 shares per trade
Previous close
₹163.05+4.75 to the close
Price band, next session
₹151.00 – ₹184.6010% either side of the close · dynamic, widened in 5% steps when hit
Day range100% of the way up
₹160.00₹167.80
52-week range79% of the way up
₹119.10 8 Jul₹181.00 4 Sept

−7.3% from the high · +41% from the low

Futures and options

No derivatives listed on BMLL

Close ₹ · Nifty 50 rebased to the first close · futures open interest by the day's build-up83 sessions to 15 Oct · axis fixed at 4 × ATR-14 around the last close
83 sessions on file · from 12 Jun
BMLL close and futures open interest over the last 83 sessions, with Nifty 50 rebased to the first close120.20158.80197.40axis spans 64%Nifty 50BMLL12 Jun12 Aug15 Oct83 sessions from 12 Jun to 15 Oct; the price axis spans 64 percent.

Quarterly results

consolidated · latest filed 27 Jul, 07:19 pm IST · NSE filings

Revenue ₹43 cr; profit ₹12 cr in the Mar 2026 quarter, consolidated.

Last 1 quarters, consolidated₹ crore as filed · year on year against the same quarter a year earlier · market: close on the first session after the filing against the last close before it, Nifty 50 over the same session
Quarterly results of BMLL on the consolidated basis with the market's move on the first session after each filing
QuarterRevenue ₹ crRevenue YoYProfit ₹ crProfit YoYEPS ₹Market on the day
Mar 2026filed 27 Jul · audited₹43 cr—₹12 cr—12.95▼ −0.3%Nifty 0.0% · −0.2 pp

Fundamentals

consolidated · filings to Mar 2026 · close ₹167.80 on 15 Oct

Fundamentals for BMLL on the consolidated basis to Mar 2026.

Valuationarithmetic on filings and the close · each cell names what it rests on · — where an input is missing
Market cap
—no NSE market-cap record yet
Price to earnings
—fewer than four consecutive quarters filed
Trailing EPS
—fewer than four consecutive quarters filed
Price to book
—no balance sheet filed yet
Book value a share
—no equity line in the filing
Debt to equity
—no equity line in the filing
Return on equity
—needs two filed balance sheets
Dividend yield
—no dividend with an ex-date in 365 days
Face value
—no NSE record yet
Shares outstanding
—no NSE record yet
Growthsums of the four quarters filed to Mar 2026 · growth against the four quarters before them · consolidated
Revenue, trailing 12 months
—fewer than four consecutive quarters filed
Revenue growth, 12 months
—needs eight consecutive quarters filed
Revenue 3-year CAGR
—needs twelve consecutive quarters filed
Profit, trailing 12 months
—fewer than four consecutive quarters filed
Profit growth, 12 months
—needs eight consecutive quarters filed
Profit 3-year CAGR
—needs twelve consecutive quarters filed

Shareholding

quarter to 28 May · none pledged · NSE filings

Promoters hold 67.7%, foreign portfolio investors 0.3%, banks and financial institutions 2.3% and individual investors 21.5%, as filed for the quarter to 28 May.

By category, last 1 quarterspercent of shares · beneath each figure, the change in percentage points against the previous quarter on file
Shareholding of BMLL by category over the last 1 quarters with the change against the previous quarter
Category28 May
Promoters67.70
Foreign portfolio investors0.29
Banks and financial institutions2.31
Individual investors21.54
Bodies corporate2.39
Others5.78

Corporate actions

NSE and BSE records

No corporate action on record for BMLL yet.

Price history

83 sessions on record · to 15 Oct · NSE end of day

BMLL is +4.9% over 20 sessions against Nifty's −2.0%, 7.3% below its 52-week high, realised volatility 54% annualised.

Returns against Nifty 50longest window first · Nifty 50 over the same sessions
Returns of the stock and Nifty 50 over six windows, longest first
WindowFrom ₹BMLL %Nifty 50 %Difference pp
60 sessionssince 15 Jul₹135.00▲ +24%▼ −4.5%+29
20 sessionssince 10 Sept₹159.99▲ +4.9%▼ −2.0%+6.9
5 sessionssince 8 Oct₹155.00▲ +8.3%▲ +3.4%+4.8
1 sessionsince 14 Oct₹163.06▲ +2.9%▲ +1.7%+1.3
Averages of the closeclose against each average
5-session average
₹159.51close +5.2% from it
20-session average
₹159.90close +4.9% from it
50-session average
₹156.38close +7.3% from it
Range and volumetrue range over 14 sessions · high to low over 20 · volume against the 20-session average
Average true range, 14
₹7.44.4% of the close
Average day's range, 20
₹5.83.5% of the close
Volume against 20 sessions
0.83×13,000 vs 16,000 average
Volatility and co-movement with Nifty 50annualised from daily log returns · counts share one denominator per cell
Realised volatility, 20
54%≈ ±3.4% a session · moved more than that on 3 of 20
Realised volatility, 60
57%≈ ±3.6% a session · moved more than that on 9 of 60
Beta to Nifty, 60
0.98moved with Nifty on 34 of 60 sessions
Up and down sessionscloses above and below the previous close
Last 20 sessions
9 up · 11 downof 20
Last 60 sessions
24 up · 36 downof 60
Best session, 250
▲ +12%29 Jul
Worst session, 250
▼ −8.3%8 Jul

0 bulletins on BMLL

The desk has not written about Bio Medica Laboratories Limited yet. The tape carries every bulletin as it is published.

About Bio Medica Laboratories Limited

exchange masters as of 18 Sept 2026 · classification by BSE
Company
Bio Medica Laboratories Limited
Exchange
NSE
ISIN
INE1BKA01015
Sessions on record
83
Price source
NSE UDiFF bhavcopy · end of day · delayed
Filings
NSE and BSE public disclosures · results, shareholding and corporate actions as filed
Computed
15 Oct, 08:03 pm IST
Bulletins
0 · written by the desk · not a recommendation

OI Charts is not a SEBI-registered investment adviser or research analyst. Prices, open interest, filings and the desk read are exchange data and arithmetic on it, not a basis for any investment decision.